BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Massachusetts Life Sciences Center, WPI Venture Forum Announce Life Sciences Winner


11/10/2011 9:19:47 AM

Waltham, MA – The Massachusetts Life Sciences Center (MLSC) and the WPI Venture Forum today announced that MedicaMetrix has been awarded $10,000 in the first-ever WPI Venture Forum Business Plan Contest Life Sciences Track competition. The new track, added to the competition for the first time this year, was funded through a sponsorship from the MLSC, the agency charged with implementing the state’s ten-year, $1 billion Life Sciences Initiative.

MedicaMetrix produces urological medical devices with demonstrated “comparative effectiveness” to reduce the cost of healthcare while improving clinical outcomes. Its first product, ProstaGlove™, is designed to improve the diagnosis and treatment of prostate cancer by enabling the use of PSA Density (PSAD) as a marker. Most males are screened for prostate cancer using PSA beginning at age 50. Men with PSA >2.5-4.0 ng/ml are referred for prostate biopsy of which approximately 75% are negative. With approximately 1.1M prostate biopsies performed in the U.S., an estimated $1.4B is wasted annually on these negative biopsies.

“A better marker for prostate cancer is PSA Density (PSAD) – PSA divided by prostate volume which identifies men at high risk for aggressive prostate cancer,” said Christopher LaFarge, CEO of MedicaMetrix “Using PSAD with a cutoff in the range of 0.11-0.18 ng/ml/cc for referral for prostate biopsy will avoid 35%-50% of prostate biopsies while capturing all aggressive prostate cancers detected under prevailing diagnostic methods. Today, however, PSAD isn’t used because the available means of measuring prostate volume, transrectal ultrasound, is prohibitively expensive at an average cost of $225/procedure. ProstaGlove™ at $30 enables low cost determination of PSAD, with potential to save hundreds of millions of dollars annually from avoided, unnecessary biopsies, and an additional $1.5 billion by focusing treatment on aggressive cancers, and avoiding invasive treatment of indolent cancers.”

For more information, visit www.medicametrix.com

“Congratulations to MedicaMetrix on their selection as a WPI Venture Forum Business Plan Contest winner,” said Susan Windham-Bannister, Ph.D., President and CEO of the Massachusetts Life Science Center. “Innovation is what makes our life sciences Supercluster in Massachusetts strong, and this terrific young company is poised to make important contributions to our economy and to patient care. We look forward to partnering with MedicaMetrix as they put down roots and grow in Massachusetts.”

“The WPI Venture Forum is driving New England entrepreneurship and innovation through public access to educational programs and services, two annual business contests, and a diverse, transparent network of peers, mentors, and academicians. We are an efficient platform that kindles and develops technology and life science venture start-up activity. ” said Gina M. Betti, Administrative Director of the WPI Venture Forum.

“We are very pleased to have had the opportunity to present at the WPI Venture Forum’s business plan contest. This win comes at a particularly propitious time as we are starting to raise money to fund clinical trials for FDA clearance,” said LaFarge. “ProstaGlove™ can potentially save the US healthcare system billions of dollars while improving outcomes for men with prostate cancer.”

A group of five Life Sciences applicants began the competition in October with in-person fifteen-minute pitches to a group of professional judges. This round of judging reduced the group to 2 finalists, who then presented ten-minute pitches to judges and the WPI Venture Forum audience on November 8, 2011. The Life Sciences Track winner was announced that evening with the award being presented by Dr. Windham Bannister.

About the Massachusetts Life Sciences Center

The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency of the Commonwealth of Massachusetts tasked with implementing the Massachusetts Life Sciences Act, a ten-year, $1 billion initiative that was signed into law in June of 2008. The Center’s mission is to create jobs in the life sciences and support vital scientific research that will improve the human condition. This work includes making financial investments in public and private institutions that are advancing life sciences research, development and commercialization as well as building ties between sectors of the Massachusetts life sciences community. For more information, visit www.masslifesciences.com.

About the WPI Venture Forum

Founded in 1991, the WPI Venture Forum (WPIVF) is an organization of entrepreneurs, investors and service providers that meet monthly between September and June at Worcester Polytechnic Institute. Programs focus on keynote technology business themes, networking, and often a start-up business case presentation and critique. The annual WPIVF Northeast US Technology Business Plan Contest provides a platform for technology entrepreneurs with new venture ideas to be screened, mentored, and prepared for final competition presentation. The competition prepares entrepreneurs with a refined pitch and for some, moving in a critical new direction. In 2011, the contest added a Life Sciences Track to enhance the business acumen of scientists wanting to commercialize research deliverables: products and processes. Open to any technology startup in the northeast United States, the competition draws a diverse applicant pool. For information about this and our other programs, visit www.wpiventureforum.org



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES